Bringing the fundamentals into focus…
Back to Tarsus Pharmaceuticals, Inc.
How Tarsus Pharmaceuticals, Inc. stacks up
TARS · against 278 other Healthcare companies of similar size
Growth
96/ 100
Near the top of its peers.
Ranked #12 of 279 · scores higher than 95% of peers
Bars: peers in each 10-point band of the growth score34 peers with a growth score of 90–100, including TARS · Click a bar to see the companies
Why growth scores 96?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 95% of peers. Revenue growth: 105.2% vs peer median 6.1%
- faster revenue growth over three years: stronger than 99% of peers. 3-year revenue growth: 264.7% vs peer median 5.8%
Metric by metric
Position: dot = TARS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TARS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 279 reported | 105.2% | 7.7% | 94% | 33% | |
| Earnings per share growthHigher is better · 174 reported | Not reported | 9.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 272 reported | 264.7% | 8.6% | 100% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around TARS| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 10 | 4.0B USD | 97 | 56 | |
| 10 | 4.4B AUD (≈$2.9B) | 97 | 51 | |
| 12 | 5.7B USD | 96 | 52 | |
| 12 | 1.9B USD | 96 | 44 | |
| 12 | 3.4B USD | 96 | 48 | |
| 15 | 1.9B USD | 95 | 49 | |
| 15 | 3.0B USD | 95 | 54 | |
| 15 | 2.0B USD | 95 | 53 | |
| 15 | 4.7B USD | 95 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score